leadf
logo-loader
viewWeedMD Inc

WeedMD strikes exclusive deal to bring Mary's Medicinals line of premium cannabis products to Canada

In addition to distribution, WeedMD will manufacture Mary’s Medicinals in house with its own input biomass at its CX Industries facility in Ontario

WeedMD Inc -
Mary’s Brands manufactures topicals, transdermal patches and gel pens under the Mary’s Medicinals line of products

WeedMD Inc (CVE:WMD) (OTCQX:WDDMF) said Wednesday it had struck a deal with US-based cannabis wellness house MM Technology Holdings LLC to bring a premium line of products to Canada.

The medical cannabis producer will become the sole Canadian distributor of Mary’s Brands, which manufactures topicals, transdermal patches and gel pens under the Mary’s Medicinals line of products.

WeedMD will manufacture Mary’s Medicinals in house with its own input biomass at its CX Industries facility in Ontario. The Toronto-based company will also market and sell Mary’s Medicinal products using its own distribution channels.

READ: WeedMD appoints prominent Canadian entrepreneur and venture capitalist Bruce Croxon to board of directors

The deal helps WeedMD to expand its cannabis offerings to address an “underserved” wellness and medical market segment, according to the company.

“As we move into the next level of product development, it’s imperative that we strategically partner with established brands that share our core values and Mary's Brands offers a superior product line that is backed by a team truly dedicated to ensuring the quality, integrity and efficacy of its product offerings,” said Angelo Tsebelis, CEO of WeedMD in a statement.

“We’re proud to be selected as Mary’s exclusive Canadian producer and distributor. With our cultivation platform and CX extraction operations fully ramped-up, there's the added pride of developing these renowned products in-house as we expand with new cannabis formats into a lucrative, yet underserved consumer segment.”

Mary’s Brands CEO Jacques Panis told investors that the Colorado-based company was “thrilled” to partner with WeedMD to expand its brand into Canada.

“Our continued desire to innovate on additional product offerings makes this partnership fitting as we look to collaborate with a strong, experienced team that brings unparalleled expertise in cultivation and extraction along with a proven ability to capture unique, next-level distribution channels,” Panis said.

WeedMD will start manufacturing Mary’s Medicinals in the fourth quarter to sell across its medical and adult-use channels.

Contact Angela at angela@proactiveinvestors.com

Follow her on Twitter @AHarmantas

Quick facts: WeedMD Inc

Price: 0.325 CAD

TSX-V:WMD
Market: TSX-V
Market Cap: $68.34 m
Follow

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

In exchange for publishing services rendered by the Company on behalf of WeedMD Inc named herein, including the promotion by the Company of WeedMD Inc in any Content on the Site, the Company receives from said issuer...

FOR OUR FULL DISCLAIMER CLICK HERE

Buds & Duds: Cannabis stocks off to slow start to the holidays; WeedMD rises...

The North American Marijuana Index, which tracks the top cannabis stocks in the US and Canada, fell 1.8% to settle at 115.4 points. Elsewhere, the Horizons Marijuana Life Sciences Index ETF lost 2.1% at C$8.99, while the OTCQX Cannabis dropped 2.3% at 444.7 points. Buds today are WeedMD Inc...

on 2/12/19

2 min read